Yüklüyor......
Data on migration of the non-invasive breast cancer cell line, MCF-7 treated with Bevacizumab using Real Time Cell Analyzer (RTCA)
Bevacizumab or Avastin® (Av), the recombinant antibody targeting VEGF, improves progression-free but not overall survival of metastatic breast cancer patients due to development of Av resistance. We showed that Av-therapy-induced inflammatory microenvironment contributes to the refractoriness to Av...
Kaydedildi:
| Yayımlandı: | Data Brief |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327074/ https://ncbi.nlm.nih.gov/pubmed/30671510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dib.2018.12.059 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|